Related Experiment Video
Updated: Sep 16, 2025

CO2-Lasertonsillotomy Under Local Anesthesia in Adults
Published on: November 6, 2019
Dexmedetomidine in pediatric tonsillectomy: a systematic review with meta-analysis
Julia M Olsen1,2, Makoto Sumie1,3,4,5, Alan Yang3
1Department of Anesthesia and Pain Medicine, The Hospital for Sick Children (SickKids), Toronto, ON, Canada.
Dexmedetomidine (DEX) significantly reduces opioid needs and emergence delirium in children undergoing tonsillectomy. It also lowers the incidence of postoperative nausea and vomiting, improving the overall perioperative experience.
Area of Science:
- Anesthesiology and Perioperative Medicine
- Pediatric Surgery
- Pharmacology
Background:
- Tonsillectomy is a common pediatric surgical procedure associated with significant perioperative pain and potential adverse events.
- Opioid analgesics are frequently used but carry risks of respiratory depression and nausea/vomiting.
- Dexmedetomidine (DEX) is an alpha-2 adrenergic agonist with sedative, analgesic, and anxiolytic properties that may mitigate these issues.
Purpose of the Study:
- To evaluate the efficacy of intravenous dexmedetomidine (DEX) in reducing perioperative opioid requirements in pediatric tonsillectomy patients.
- To assess the secondary effects of DEX on perioperative respiratory adverse events (PRAE), emergence delirium (ED), and postoperative nausea and vomiting (PONV).
Main Methods:
- A systematic review and meta-analysis of randomized controlled trials (RCTs) was conducted.
- Included studies compared intravenous DEX plus opioids versus opioids alone in pediatric patients undergoing tonsillectomy.
- Primary outcome was perioperative opioid consumption (oral morphine equivalents); secondary outcomes included PRAE, ED, and PONV.
Main Results:
- Dexmedetomidine significantly reduced perioperative opioid requirements by approximately 40% (MD, -0.25 mg·kg⁻¹ OME).
- DEX was associated with a lower incidence of emergence delirium (RR, 0.24), with a dose-dependent reduction observed.
- While DEX did not significantly impact respiratory adverse events like cough, it effectively reduced postoperative nausea and vomiting (RR, 0.48).
Conclusions:
- Intravenous dexmedetomidine shows promise in improving the perioperative course for pediatric tonsillectomy.
- DEX effectively decreases opioid consumption and emergence delirium, with a notable dose-response relationship for delirium.
- Further research may be needed to address inconsistencies in reporting perioperative respiratory adverse events.
Related Concept Videos
Parenteral Anesthetics: Overview
Skeletal Muscle Relaxants: Therapeutic Uses
Inhalational Anesthetics: Overview
Tonsillitis II: Management
General Anesthesia: Overview
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
Stages of General Anesthesia

